| Next 10 |
Ad
AVXL News and Press Anavex Life Sciences Corp.
News | Anavex Life Sciences Corp. (NASDAQ:AVXL)
-
2023-09-18 08:16:42 ET SeqLL ( NASDAQ: SQL ) +70% . TradeUP Acquisition ( UPTD ) +11% . Tian Ruixiang Holdings ( TIRX ) +11% . Virios Therapeutics ( VIRI ) +9% terminates at-the-market sales agreement. Village Farms Inter...
-
2023-09-15 09:56:55 ET Summary On Thursday, Sep 14, Anavex Life Sciences released additional data from their phase 2b/3 Alzheimer's Disease trial. The company stated that (after a new post hoc analysis), the trial showed statistically significant results in one primary endpoint (A...
-
2023-09-14 13:02:36 ET More on Alzheimer's drug developers Cassava Sciences: Insiders Purchasing Stock, Is The Market Still Buying Simufilam? Prothena: Dunn Appointment And Bristol Opt-In Boost Validation Anavex Life Sciences: Multiple CNS Shots On Goal Awaiting Conv...
-
2023-09-14 07:59:22 ET More on Anavex Life Sciences Anavex Life Sciences: Multiple CNS Shots On Goal Awaiting Convincing Data Anavex: Will Be An Interesting Endgame To Watch Anavex lead candidate shows promise for Rett syndrome Anavex taps Partex to use AI fo...
-
NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders...
-
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders...
-
2023-09-07 11:04:48 ET More on Lilly, Novo, etc. Novo Nordisk: Super Focused Pharma Company For The Long Run Novo Nordisk: Strong Fundamentals Meet Technical Uptrends Eli Lilly And Novo Nordisk: Are Weight Loss Drugs A Global Revolution Or Short-Lived Fad? Se...
-
2023-08-18 17:02:10 ET Gainers: Anavex Life Sciences ( NASDAQ: AVXL ) +10% . Palo Alto Networks ( PANW ) +9% . Fluence Energy ( FLNC ) +5% . Stronghold Digital Mining ( SDIG ) +4% . Zscaler ( ZS ) +4% . Losers: NAPCO ...
-
2023-08-17 18:42:16 ET Summary Taysha Gene Therapies has made significant progress with its gene therapy, TSHA-102, for the treatment of Rett Syndrome. Positive results were observed in the first patient treated with TSHA-102, showing improvement in key efficacy measures. The ...
-
2023-08-08 09:40:27 ET Anavex Life Sciences Corp. (AVXL) Q3 2023 Earnings Conference Call August 08, 2023, 08:30 AM ET Company Participants Clint Tomlinson - IR Christopher Missling - President and CEO Sandra Boenisch - Principal Financial Officer Conferenc...
Stock Information
Anavex Life Sciences Corp. Company Name:
AVXL Stock Symbol:
NASDAQ Market:
Anavex Life Sciences Corp. Website:
Ad
-
NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders...
-
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceu...
-
NEW YORK, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders...